Oxford Nanopore Technologies’ (ONT) “Overweight” Rating Reiterated at JPMorgan Chase & Co.

JPMorgan Chase & Co. reaffirmed their overweight rating on shares of Oxford Nanopore Technologies (LON:ONT) in a research report sent to investors on Friday,London Stock Exchange reports.

A number of other research firms have also commented on ONT. Berenberg Bank restated a “buy” rating and set a GBX 282 ($3.59) price target on shares of Oxford Nanopore Technologies in a research report on Tuesday, September 3rd. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 190 ($2.42) target price on shares of Oxford Nanopore Technologies in a report on Wednesday, September 4th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of GBX 235.50 ($3.00).

Oxford Nanopore Technologies Price Performance

LON:ONT opened at GBX 149.85 ($1.91) on Friday. The company has a quick ratio of 6.01, a current ratio of 4.45 and a debt-to-equity ratio of 8.07. The firm has a market cap of £1.41 billion, a PE ratio of -750.00 and a beta of 0.80. Oxford Nanopore Technologies has a 12 month low of GBX 85 ($1.08) and a 12 month high of GBX 212.59 ($2.71). The company’s 50-day moving average price is GBX 143.58 and its two-hundred day moving average price is GBX 126.92.

Insider Buying and Selling

In other news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the firm’s stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of GBX 142 ($1.81), for a total value of £2,830,870.82 ($3,607,583.56). Insiders purchased 306 shares of company stock worth $44,850 in the last quarter. Insiders own 32.62% of the company’s stock.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.